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ABSTRACT 
OBJECTIVES: To assess the effects of a regular exercise programme on metabolic 
control and also knowledge, attitude and practice (KAP) of exercise and physical 
activity among Type 2 diabetes mellitus patients. 
MATERIAL AND MET{{ ODS: Forty two Type 2 diabetes patients from the 
community medicine and medical specialist clinics in USM were assigned . to two 
groups; The interventive group consisted of 13 males and 14 females, mean age 
52.6(8.7) (mean (SD)), body mass index 27.2 (3.9) participated in regular group 
exercise sessions (3 times a week, 1 hour sessions) for 7 weeks. Exercise intensity was 
predetermined based on the predicted target heart rate for each subject. The control 
group consisted of 7 males and 8 females, mean age 56.5(11.1), body mass index 
25.8(2.73). Pre and post-intervention anthropometric measurements and blood 
investigations were done. These include height, weight, body mass index, body fat 
percentage and fat free mass (FFM), blood pressure, cardiorespiratory fitness level, 
fasting plasma glucose level (FPG), HbA I c level, fasting lipid profile, insulin and C-
peptidelevel. 
RESULTS:, In the intervention group, FFM increased from 45.98(9.71) to 47.93(10.53) 
kg,; percentage body fat decreased from 32.37(11.02) to 30.14(10.73)%. Diastolic 
pressure reduced from 91(11.2) to 83.3(7.5) mmHg, cholesterol level decreased from 
6.23(1.03) to 5.74(1.23) mmoVI, HDL level increased from 0.97(0.31) to 1.19(0.28) 
mmolll. Estimated V02max increased from 21.6(7.04) to 27.7(8.72) mllkg/min. Resting 
heart rate declined significantly from 80(7) to 73( II) bpm. There was no improvement 
in body mass index (BMI), fasting plasma glucose, insulin and C-peptide levels. 
Knowledge and attitude scores were higher than practice scores. 
XI 
CONCLUSION: Seven weeks of exercise intervention among type 2 diabetes patients 
resulted in an improvement in body composition, cardiorespiratory fitness, lipid profile 
and a reduction in blood pressure. However there is a disparity between knowledge and 
practice of exercise and physical activity. 
xii 
1.1 
CHAPTER I 
INTRODUCTION 
Recent figures from Diabetes Adas 2000 published by the International Diabetes 
Federation (IDF) revealed that over 150 million adults around the world have diabetes, 
an II% increase in just ~ years (1995-2000)(IDF, 2000). The prevalence of diabetes is 
presently higher in developed countries than in developing countries, but the developing 
world will be more seriously affected by the escalating diabetes epidemic in the future. 
Even more alarming is the increasing numbers of younger (and productive) diabetics 
seen especially in developing countries. This substantial rise in diabetes is contributed 
to the urbanisation, westemisation and economic development in developing countries 
(Jerval, 1997). The above changes inadvertently bring about concomittant changes in 
lifestyle and diet, the two most important external contributing factors for type 2 
diabetes. Morbidity and mortality in type 2 diabetes is mainly due to cardiovascular 
disease, as a result of hypertension, dyslipidemia, smoking, obesity and lack of exercise 
(Fuller et al, 1983). In Malaysia, the prevalence of diabetes ranges from 4-8% 
(Mustaffa, 1990) and is expected to exceed 10% by the year 2020 (Anuar, 1997). This 
means that with a 21 million population estimate in 1996, the number of diabetics in 
Malaysia would number about 1. 7 million. Of these, about 95% would be having type 2 
diabetes mellitus (Ministry of Health 1997). Management of this serious health threat 
requires effective preventive and therapeutic measures. Prevention of diabetes either at 
the primary or secondary level is directed primarily towards a change in lifestyle and 
diet i.e. from a sedentary to a more physically active lifestyle coupled with a healthy 
and balanced diet. Primary treatment of type 2 diabetes is mostly non pharmacological 
i.e. diet therapy combined with exercise. This treatment modality has in fact been 
recommended for the treatment of diabetes for over 2000 years and is still effective 
when optimally utilised (Eriksson, 1999). Exercise is also one of the three main 
approaches (including diet and education) to managing type 2 diabetes and impaired 
glucose tolerance (IGT) patients in Malaysia (Ministry of Health, 1997). A trial of 
therapy for at least 3-6 months of prudent exercise, diet and a healthy lifestyle should be 
advocated before any OI:al hypoglycaemic agents (OHA) are prescribed. Even when 
OHA are being used, emphasis should still be put on a proper diet, regular exercise and 
compliance at all levels. 
Guidelines on a suitable diet for type 2 diabetics are usually given by the attending 
physician or when available by a resident dietitian. However advice on exercise is 
usually provided by the attending physician based on the guidelines provided by the 
Ministry of Health (Ministry of Health, 1997). As there will be different levels of 
involvement in physical activity or exercise in different community groups (Walker et 
al, 1999), the exercise programme prescribed has to be 'tailored' to suit the different 
groups, especially so for the majority of type 2 diabetics who would most likely be 
elderly and/or obese. The experience of the Universiti Sains Malaysia (USM) obesity 
clinic has shown that obese subjects who underwent a proper weight reduction 
programme in the form of dietary counselling, behaviour modification and exercise 
achieved a significant amount of weight loss (Wan Manan et al, 1998). In another 
similar study, dietary and physical activity intervention resulted in significant increase 
in V02max and decrease in weight, body mass index (BMI), fasting glucose levels, 
insulin, total cholesterol, triglycerides and systolic blood pressure. In this study the type 
of exercise used was brisk walking, step aerobics or line dancing, 5 days a week (Wing 
et al, 1998 ). 
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The current project aims at evaluating the effects of a structured exercise programme in 
a group of type 2 diabetic patients at USM Kubang Kerian. 
1.2 Study hypothesis 
A well-managed and structured exercise programme can improve metabolic control, 
body composition, lipid p.rofiles and cardiorespiratory fitness of type 2 diabetes mellitus 
patients. 
1.3 Objectives 
1. To detennine the proportion of overweight (BMI > 25 kglm2) and obesity (BMI > 
30 kg/m2) among type 2 diabetes patients. 
2. To detennine the proportion of uncontrolled diabetes {HbAlc > 8%) or fasting 
plasma glucose {FPG) > 7 mmoVl in type 2 diabetes patients. 
3. To determine the proportion of hypertension {systolic blood pressure (SBP) > 140 
mm Hg, diastolic blood pressure (DBP) > 90 mm Hg). 
4. To detennine the levels of fasting plasma insulin and C-peptide in type 2 diabetes 
patients. 
5. To determine the levels of triglyceride, total cholesterol and high density 
lipoproteins in type 2 diabetes patients. 
6. To estimate the cardiovascular fitness of type 2 diabetes patients. 
7. To assess the effects of a regular structured exercise programme on all the above 
mentioned parameters. 
8. To assess the knowledge, attitude and practice of exercise tn type 2 diabetes 
patients. 
3 
1.4 Study Expectations 
Exercise interventional studies done at other centers have shown positive changes in 
metabolic control (FPG, HbAic, insulin, C-peptide levels), lipid profile, body 
composition (body mass index (BMI), percentage body fat, fat free mass) and reduction 
in blood pressure (Mourier et al, 1997; Yamanouchi et al, 1995; Lehmann et al, I 995). 
The present study is an attempt at establishing a suitable and effective exercise 
programme which could be easily followed by the local subjects and thus could 
consequently produce similar positive changes in the metabolic control of type 2 
diabetes patients. 
4 
2.1 Diabetes Mellitus 
CHAPTER2 
LITERATURE REVIEW 
Diabetes mellitus is a group of metabolic disorders characterized by chronic 
hyperglycemia resulting fr_9m abnormalities in insulin secretion, insulin action or both. 
Diabetes is associated with long-term complications that affect almost every part of the 
body. It is associated with long-term damage, dysfunction and failure of multiple organs 
especially the eyes, kidneys, heart and blood vessels. The disease often leads to 
blindness, heart and blood vessel disease, strokes, kidney failure, diabetic gangrene, and 
nerve damage. Uncontrolled diabetes can complicate pregnancy, and birth defects are 
more common in babies born to women with diabetes. Signs and symptoms of marked 
hyperglycemia include polyuria, polydipsia, weight loss, and blurred vision. Growth 
may be impaired and patients are more susceptible to infections. Acute emergencies of 
diabetes include hyperglycemia with ketoacidosis or non ketotic hyperosmolar 
syndrome. Patients with diabetes have an increased incidence of atherosclerotic 
cardiovascular, peripheral vascular and cerebrovascular disease. Hypertension and 
abnormalities of lipoprotein metabolism are often found in diabetic patients. The 
emotional and social impact of diabetes and the demands of therapy may cause 
significant psychosocial dysfunction in patients and their families. 
2.2 Classification of Diabetes Mellitus 
The World Health Organisation (WHO) Expert Committee on diabetes in 1980 and later 
the WHO Study Group on Diabetes Mellitus ( 1985) recognized two major fonns of 
diabetes; insulin-dependent diabetes mellitus (IDDM, type I diabetes) and non-insulin _ 
5 
dependent diabetes mellitus (NIDDM, type 2 diabetes) including three other distinct 
types viz. gestational diabetes mellitus (GDM), malnutrition-related diabetes mellitus 
(MRDM) and other types (WHO 1985). The WHO and the National Diabetes Data 
Group (NDDG) highlighted the heterogeneity of the diabetic syndrome which share 
hyperglycemia in common. The degree of hyperglycemia may change over time, 
depending· on the extent_ of the underlying disease (Figure 2.1) (American Diabetes 
Association (ADA) Expert Committee Report, 1998). 
The vast majority of cases of diabetes falls into two broad categories. In one category 
(type 1 diabetes), the cause is an absolute deficiency of insulin secretion. Individuals at 
increased risk of developing this type of diabetes can often be identified by serological 
evidence of an autoimmune pathologic process occurring in the pancreatic islets and by 
genetic markers. In the other, much more prevalent category (type 2 diabetes), the cause 
is a combination of resistance to insulin action and an inadequate compensatory insulin 
secretory response. In this category, a degree of hyperglycemia sufficient to cause 
pathologic and functional changes in various target tissues, but without clinical 
symptoms, may be present for a long period of time before diabetes is detected. During 
this asymptomatic period it is possible to demonstrate an abnormality in carbohydrate 
metabolism by measurement of plasma glucose in the fasting state or after a challenge 
with an oral glucose load. The main characteristics of the two main types of diabetes 
(type I and 2) are listed in TABLE 2.1. 
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Figure 2.1 Disorders of glycemia : etiologic types and stnges. Block arrows represent 
the spectrum of disease stettes. ft Even afier presenting in ketollcidosis, these patients 
can· briefly return to 1ionnoglycernia without requiring continuous therapy (i.e. 
"honeymoon" retnission). *~« In rare instances, patients in these categories (e.g. type I 
diabetes presenting in pregnancy) may requ~re insulin for survival. (Expert Committee 
on the Diagnosis and Classification of Diabetes Mellilus .. 1998) 
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TABLE 2~1 Cbamcteristics of Type I and Type 2 Diabetes Mellibis 
Characteristics 
·Patient at risk 
Onset 
crassical symptoms 
f mmune markers 
Genetic markers 
Treatment 
NIDOM lOOM 
Pooitive fumity histo;y--·- ------:---positive family history·-----------·· 
otiese .. 
H~pertensive 
Insidious . 
Older age group at onset 
>40 years 
Sofnetimes absence of classical 
syfuptorns 
· Athen~ of ketonuria or 
kdoacidos.is 
C-(leptide positiye 
GAD antibody usually negativ~ 
No characteristic HLA type 
Diet. oral hypoglycaemic agent or 
sotnetimes insulin 
Acute 
Younger age at pre.~aitation. 
<40 years 
Polyuria 
Ketonuria 
Ketoacidotic 
Loss ·or weight 
Presence of islet ceil antibody · 
(for 18 months or so after diagnosis) 
GAD antibody positive 
Particular HLA type: DO, DRJ. OR4. 
DRJ/DR4 
Need insulin for life 
I 
I 2.3 Diagnosis of Diabetes Mellitus Clinical diagnosis of diabetes is based essentially on presence of hyperglycemia. Based 
on WHO diagnostic criteria (World Health Organisation, 1985), a fasting plasma 
glucose (FPG) concentration greater than 7.8 mmol/1 or a random plasma glucose 
concentration greater than 11.1 mmol/1 is diagnostic of diabetes. If blood glucose levels 
are borderline, and there is cause for doubt about the presence of diabetes, a glucose 
tolerance test (GTT) should be performed. In symptomatic patients, a single abnormal 
blood or plasma glucose level is adequate for the diagnosis of diabetes; but if symptoms 
are absent, then two abnormal levels are needed. 
2.4 Management of Diabetes 
The goal of diabetes management is to relieve symptoms, to enable the patient to lead a 
normal life, to prevent acute and chronic complications, to reduce mortality and to treat 
accompanying disorders. The principal means to achieve the above objectives is by 
keeping blood glucose levels as close to the normal range as safely possible. Studies of 
patients with type I and type 2 diabetes have provided clear evidence that therapeutic 
approaches should target the lowest blood glucose levels attainable without 
unacceptable hypoglycemia or other adverse effects. Long-term results of the Diabetes 
Control and Complications Trial (DCCT) on type 1 diabetes (DCCT, 1993) as well as 
the United Kingdom Prospective Diabetes Study (UKPDS, 1998) and the Japanese 
Kumamoto Study on type 2 diabetes (Ohkubo et a/, 1995) has shown that intensive 
therapy aimed at achieving tight glycaemic control reduces the micro- and 
macrovascular complications associated with diabetes. The main therapeutic tools 
commonly used to achieve this target include lifestyle modifications (diet and physical 
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activity/ exercise), oral hypoglycemic agents and/ or insulin. These are often prescribed 
singly or in combination to diabetic patients to achieve optimal glycaemic control. 
2.3.1 Diet 
Diet modification is the pnme treatment for type 2 diabetes, whereas for type I 
diabetics it is an importanJ secondary treatment option. The mainstay of diet therapy for 
Type 2 diabetics who are obese is restriction of saturated fat <1 0 % of total dietary 
energy, reduction of energy intake and lowering of body weight. Dietary management 
of typel diabetics should aim in the short term to prevent hypoglycemia and ultimately 
reduce the risks of chronic diabetic complications and improve life expectancy. Dietary 
advice must take into account the individual preferences, attitudes and lifestyle in order 
for it to be effective (Pickup and Williams, 1997). 
2.4.2 Oral Hypoglycemic Agents (OHA) 
These are primarily used to treat type 2 diabetes and are used to correct the underlying 
metabolic disorders, namely insulin resistance and inadequate insulin secretion. The 
three main groups are the sulphonylureas, the biguanide metformin and the a.-
glucosidase inhibitor acarbose. Sulphonylureas such as glibenclamide and gliclazide 
lower blood glucose primarily by stimulating the second phase of insulin secretion. 
Metformin lowers blood glucose levels via several mechanisms, including inhibition of 
gluconeogenesis in the liver and thus suppression of hepatic glucose production; 
improving peripheral insulin sensitivity and promoting glucose uptake and storage in 
muscle. Metformin also causes weight loss (unlike sulphonylureas) and is therefore 
useful for obese patients. The a-glucosidase inhibitor acarbose, delays carbohydrate 
absorption from the gut and is usually used together with the other OHA. Other newer 
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drugs include the insulin-sensitising thiazolidinediones and insulin secretagogues 
(Pickup and Williams, 1997). 
2.4.3 Insulin 
Insulin is used in various forms and regimes to treat both type 1 and type 2 diabetes. 
Insulin via· injection or an_ insulin pump are the basic therapies for type 1 diabetes. The 
amount of insulin must be balanced with food intake and daily activities. Only type 2 
diabetics who fail to respond to combinations of OHA are treated with insulin 
injections. 
2.5 Type 2 Diabetes Mellitus 
In Malaysia, the majority of diabetic patients, up to 95%, fall into this category of 
diabetes (Ministry of Health Malaysia, 1997). The actual aetiology of this syndrome is 
not known. However, epidemiological data indicate that both genetic and environmental 
factors are involved. Identified risk factors for type 2 diabetes are age, gender, 
inheritance, obesity (degree and duration), body fat distribution, physical inactivity, 
dietary components (Perry et al, 1993), together with hyperinsulinemia and insulin 
resistance (Lundgren et a/, 1990; Boyko et al, 1991 ). 
2.5.1 Pathogenesis and Natural History 
Type 2 diabetes can be viewed as the consequence of a series of pathophysiologic 
changes; each of which makes the patient vulnerable to subsequent disruption of normal 
glucose homeostasis. The pathogenesis of type 2 diabetes involves the development of 
insulin resistance associated with compensatory hyperinsulinemia, followed by 
progressive P-cell impairment that results in decreasing insulin secretion and 
t I 
hyperglycemia. Insulin resistance denotes the inability of insulin to produce its usual 
biological effects at circulating concentrations that are effective in normal subjects. 
Hyperglycemia itself causes additional inhibition of insulin secretion and more insulin 
resistance (glucose toxicity), which further accentuates the hyperglycemia. Thus the 
development of type 2 diabetes is usually characterized by impaired insulin action 
(insulin resistance) and deficient insulin secretion (f3-cell abnormalities) (Groop et al, 
1993). The above suggested natural history of type 2 diabetes is illustrated in Figure 2.2. 
The mode of insulin secretion during this pathological process has been referred to as 
the 'Starling curve of the pancreas' (Figure 2.3). Another contributing metabolic defect 
is an elevated hepatic glucose production due to hepatic insulin resistance (De Fronzo et 
al, 1992). These pathological processes may take several years and are not necessarily 
irreversible. Ideally the treatment modality chosen should be able to modify all of the 
abovementioned abnormalities. However this kind of treatment is still not available 
although various interventions such as weight loss, increased physical activity and also 
insulin sensitising drugs are able to reduce the likelihood of progression to overt type 2 
diabetes (Eriksson, 1999). 
2.5.2 Associated Disorders 
Type 2 diabetes is often associated with other metabolic abnormalities which Reaven in 
1988 called them as Syndrome X. The metabolic syndrome is a multifaceted syndrome 
characterised by five major abnormalities: obesity, hypertension, insulin resistance, 
glucose intolerance (impaired glucose tolerance/type 2 diabetes) and dyslipidemia 
(hypertriglyceridemia and low HDL-cholesterol). In addition, a number of other 
abnormalities such as microalbuminuria, hyperuricemia, hyperfibrinogenemia and 
12 
Environmental Factors 
Overeating } Obesity 
Inactivity } 
Smoking 
Diabetogenic drugs 
l 
Genetic Genetic 
Factors Factors 
Unknown Unknown 
l l 
Impaired Glucose 
tolerance 
Environmental Factors 
Pregnancy 
Endocrine diseases 
Diabetogenic drugs 
Malnutrition in utero 
l 
Worsening beta cell 
function 
? Amyloid deposition 
Malnutrition in utero 
Figure 2.2 Hypothetical scheme of the natural history of type 2 diabetes showing 
possible interactions between insulin resistance and beta cell function (Pickup and 
Williams, 1997) 
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Figure 2.3 The 'Starling curve of the pancreas'. Insulin secretion increases initially to 
overcome insulin resistance, but reaches a plateau and then fails. Blood glucose levels 
rise initially within the normal range, then into the category of impaired glucose 
tolerance (IGT), and finally into overt type 2 diabetes. (Pickup and Williams, 1997) 
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increased levels of plasminogen activator inhibitor I and low concentrations of tissue 
plasminogen activator are often associated with the syndrome. The clinical importance 
of this syndrome is the clustering of simultaneously occurring atherosclerotic risk 
factors in the same individual (Eriksson et a/, 1997). Thus when discussing treatment 
for type 2 diabetes we should not only concentrate on the reduction of hyperglycemia, 
but also consider all the <?ther usually coexisting metabolic abnormalities (e.g. obesity, 
dyslipidemia, hypertension). In other words, the treatment goal is to correct all 
metabolic abnormalities and to lower the increased morbidity and mortality associated 
with the disease. 
2.5.3 Physical Activity and Type 2 diabetes 
The World Health Organisation (WHO) defines physical activity as all movements in 
everyday life, including work, recreation, exercise and sporting activities (WHO, 1997). 
Why exercise? The reason is simple, because exercise has numerous benefits ranging 
from a feeling of overall well being to achieving specific health benefits. Indeed high 
physical activity levels have been associated with lower risk of developing 
cardiovascular disease (Paffenbarger et a/, 1994) and a reduced chance of developing 
type 2 diabetes (Manson eta/, 1992). Furthermore it has been shown in several recent 
epidemiological studies that the level of physical activity is associated with a lowered 
incidence of type 2 diabetes (Manson et a!, 1991, 1992; Perry et a/, 1993 ). A lower 
prevalence of diabetes was also found among female former college athletes as 
compared with non-athletes (Frisch et a!, 1986). A ten year study of 200 type 2 diabetic 
patients enrolled in a physical training program showed an increase in vo2 max, 
reduction in blood pressure, heart rate, body weight, fasting plasma glucose, 
glycosylated hemoglobin and triglycerides (Schneider et a!, 1992). Exercise has a 
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pronounced effect on substrate utilisation and muscle glucose uptake can increase by up 
to 20-fold during exercise (Eriksson, 1999). Exercise-induced stimulation of glucose 
uptake may involve several factors. Firstly, increased muscle blood flow enhances 
insulin delivery to muscle by apening previously non-perfused capillaries, thus 
increasing both the effect of insulin and the surface area for glucose transport. Secondly, 
muscle contraction can stimulate glucose transport, possibly through translocation of 
glucose transporters ... (GLUT -4) from an intracellular pool into the cell membrane. 
Exercise and insulin have additive effects on muscular glucose transport, indicating two 
separate glucose transport systems; one insulin dependent and the other contraction 
dependent (Pickup and Williams, 1997). 
Physical training enhances whole-body as well as hepatic insulin sensitivity (DeFronzo 
et al, 1987). The mechanisms contributing to the enhanced insulin sensitivity in 
endurance trained athletes are increased muscle blood flow, elevated muscle glucose 
transport protein (GLUT -4) levels and glycogen synthase activity (Houmard et a/, 
1991 ). This improvement in glucose disposal lasts for months after the training 
programme ends. During intensive training programmes, glycaemic control also 
improves. A period of as short as I week of intense physical training (68% V02max) 
has been shown capable of improving oral glucose tolerance in type 2 diabetic men 
(Rogers eta/, 1988). Glycosylated hemoglobin levels may fall by 14% after 6 weeks of 
training, due to the cumulative effects of individual bouts of exercise (Schneider et a/, 
1984 ). Physical training also improves cardiovascular risk profiles: 20% decrease in 
triglycerides, 23% increase in high-density lipoprotein levels, reduces systolic and 
diastolic blood pressures (Horton, 1988; Lehmann et a/, 1995) and reduces visceral 
adipose tissue (VAT) (Mourier et a/, 1997). However habitual, less intensive physical 
exercise does not necessarily improve glycaemic control (Vanninen et al, 1992) nor 
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insulin, lipid profile or lipoprotein levels (Lampman et a/, 1987). Improved glycemic 
control as reflected in glycosylated hemoglobin or fasting plasma glucose levels has 
also been documented after 6 to 12 weeks of an aerobic exercise programme (Devlin, 
1992). This enhanced glycemic control appears to result not only from the acute effects 
of exercise (via increased skeletal muscle glucose disposal and repeated cycles of 
glycogen depletion and resynthesis) but also from a true training effect. A single 
exercise session has been shown to increase insulin sensitivity for 16 hours -or longer 
(Devlin et a/, 1987) and a particularly intense bout (85% of V02 max, continued to 
exhaustion) is able to increase glucose utilisation 12 hours later to a level comparable to 
what is achievable after 12 weeks of moderate training (Devlin, 1992). However, insulin 
sensitivity appears to correlate with increased capillarisation of skeletal muscle (Richter 
eta/, 1992) and increased capillary density (by reducing in diffusion distance) may also 
enhance positive metabolic changes in obese diabetics who exercise (Maynard, 1991 ). 
With repeated exercise, muscle hypertrophy (with increased glucose metabolism) and 
increases in V02 max can occur. In addition, psychological benefits associated with 
exercise such as improvements in mood, self-esteem, and quality of life are particularly 
important for people having chronic diseases such as diabetes (Rodin, 1989). Exercise 
and organised sports allow diabetic patients to participate in social activities. Mature 
diabetic patients can enjoy the company of similarly aged participants in an exercise 
programme or while walking in the park. This active participation promotes 
socialization, peer acceptance and personal esteem. Having exercise as part of their 
treatment regimen allows patients to take an active and positive role in management of 
their disease. 
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2.5.4 Recommendations for Exercise in Type 2 diabetes 
Undoubtedly exerctse training plays an important role in the treatment of type 2 
diabetes. It however remains a problematic treatment option. Just as diet and drug 
therapy, exercise has to be prescribed for the individual depending on the overall 
condition of the patient. The exercise prescribed should ideally bring about a regular 
and permanent change in -physical activity levels as only then will it benefit the patient. 
Frequently asked questions are, "How much exercise is enough?, and "What type of 
exercise is best for developing and maintaining fitness?". Before these questions can be 
answered a distinction has to be made between physical activity as it relates to health 
versus fitness. The American Colleges of Sports Medicine (ACSM, 1998) pointed out 
that the quantity and quality of exercise needed to attain health-related benefits may 
differ from what is recommended for fitness improvements. Lower levels of physical 
activity (particularly intensity) are generally required to exert positive metabolic 
changes and reduce risks for certain chronic degenerative diseases (ACSM, 1998). Even 
regular daily walking combined with diet therapy not only reduced body weight but also 
improved insulin sensitivity (Yamanouchi et al, 1995). Advice should thus be tailored to 
the individual's need taking into account his or her fitness and interests. 
2.5.5 Exercise Prescription for Individuals With Type 2 Diabetes 
Before beginning an exercise program, individuals with diabetes should have a medical 
evaluation to screen for macrovascular and microvascular complications that may be 
exacerbated by exercise. The examiner should screen for cardiovascular health 
' 
peripheral arterial disease, retinopathy, nephropathy, and peripheral and autonomic 
neuropathy. A graded exercise test is recommended to screen for cardiovascular disease 
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in individuals who meet any of the criteria in Table 2.2 and who wish to participate in 
moderate- to high-intensity exercise programs (American Diabetes Association, 2000). 
The American College of Sports Medicine (ACSM) recommendations (Table 2.3) for 
all individuals (including those without diabetes) is that aerobic physical activity be 
done a minimum of 3 to 5 days a week, for 20 to 60 minutes at 40% to 85% of 
maximum· oxygen uptake reserve (V02R or heart rate reserve [HRR]), or at 55% to 90% 
of maximal heart rat~ (MHR)(Pollock et al, 1998). For less conditioned individuals, 
exercise c_an be done at the lower intensity level for a longer duration, at least until a 
higher level of fitness can be achieved. Individuals with type 2 diabetes should 
especially be encouraged to progress to a higher total duration of exercise (e.g. 1 hour 
daily) to facilitate fat loss. 
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TABLE 2.2 Criteria* for Assessing the Need for Graded Exercise Testing Among 
Patients Who Have Type 1 or Type 2 Diabetes (American College of Sports Medicine 
(ACSM) Recommendations 1998) 
Age > 3 5 years 
Type 2 diabetes > 1 0 years duration 
Type I diabetes > 15 years duration 
Presence of any additional risk factor for coronary artery disease 
Presence of microvascular disease (proliferative retinopathy or nephropathy, including 
microalbum inuria) 
Peripheral vascular disease 
Peripheral and autonomic neuropathy 
*If an individual meets any one of these criteria, exercise testing is recommended prior 
to participation in moderate- to high-intensity exercise programs. 
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TABLE 2.3 American College of Sports Medicine Guidelines for Aerobic Exercise 
Programs (American College of Sports Medicine (ACSM) recommendations 1998) 
Exercise Characteristic Recommendation* 
Mode 
Intensity 
Duration 
Frequency 
exercise 
... Continuous, rhythmic, prolonged activities using the large muscle 
groups of the arms and/or legs 
Range of 55%-90% of maximal heart rate, 40%-85% of V02R or 
HRR, or RPE of 12-16 (somewhat hard to hard) 
Minimum of 20-60 min of continuous aerobic activity to improve 
fitness and endurance capacity 
Minimum of 3-5 days/wk, with frequency determined by 
duration and intensity 
Rate of progression Initial conditioning of 4-6 wk, improvement phase lasting 4-5 
mo, 
and maintenance thereafter 
*Resistance-type and flexibility training are recommended 2-3 days per week. 
V02R = V02 reserve; HRR = heart rate reserve; RPE = rating of perceived exertion 
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2.5.6 Monitoring Intensity of Exercise 
Exercise intensity can be prescribed and monitored in several ways. Oxygen uptake 
reserve (V02R) is a percentage of the difference between maximal and resting oxygen 
uptake (V02) (Swain and Leutholtz; I 997). If metabolic data from an exercise stress test 
are available, a target V02 can be determined at a desired percentage of V02R and then 
translated into a workload. for a given exercise. For practical purposes, exercise intensity 
is usually established using heart rate. 
Calculation of a training heart rate or range using the heart rate reserve {HRR) method 
(Karvonen equation) is done with the following formula: 
Training HR = intensity fraction x (HRmax - HRrest) + HRrest 
where the intensity fraction is chosen between 0.40 and 0.85 (the lower end of the range 
is used for patients with low initial fitness) and HR rest is the resting heart rate. A 
known value of maximum heart rate {HRmax), obtained from a maximal stress test, 
should be used if available; otherwise, HRmax may be estimated by subtracting the 
patient's age from 220. 
For example, calculation of a training HR at 50% of HRR for a patient with a maximal 
HR of 170 beats per minute (bpm) and a resting HR of 80 bpm would result in a training 
HR of 125 bpm: 
Training HR = 0.50 x ( 170 - 80) + 80 = 45 + 80 = I 25 bpm. 
2.5. 7 Resistance training 
More recently resistance training has been shown to have a positive effect on metabolic 
profile of type 2 diabetes patients (Eriksson et al, 1997; Honkola et al, I 997). Resistance 
or weight training that includes at least one set of each of 8 to l 0 different exercises 
using the major muscle groups is recommended 2 to 3 days a week. Each set should 
22 
consist of 8 to 12 repetitions, with the amount of weight increased when the individual 
can complete 12 or more repetitions. For those age 50 or older who have diabetes or 
preexisting health concerns such as hypertension, more repetitions ( 12 to 15) done at a 
lower weight may be more suitabl~ Flexibility training should be incorporated into the 
overall fitness routine a minimum of 2 to 3 days per week to develop and maintain joint 
range of ·motion and to minimise the potential loss of flexibility resulting from 
... 
glycosylation of various joint structures. Stretching for 5 to I 0 minutes should be done 
either after an aerobic warm-up or following the completion of an exercise session. 
2.5.8 Warm-up and Cooldown 
No matter what type of activity is done, the standard recommendation for all individuals 
(with or without diabetes) is to include proper warm-up and cooldown periods. A warm-
up consists of 5 to l 0 minutes of a lower-intensity aerobic activity that uses the same 
muscles that will be exercised at a higher intensity (e.g. walking before starting to jog). 
The cooldown consists of 5 to l 0 minutes of less intense activity. Such activities may 
ease the cardiovascular transition between rest and exercise and help prevent muscle 
and joint injuries. 
2.6 Exercise Recommendations for Blood Glucose Management 
For individuals with type 2 diabetes who are not using supplemental insulin, the risks 
for hypoglycemia are less compared to patients with type 1 diabetes. Supplemental 
carbohydrates are generally not needed in these patients; however, blood glucose 
monitoring will reveal which individuals may need additional carbohydrates to prevent 
hypoglycemia during and following exercise. Use of certain oral hypoglycemic agents 
such as sulfonylureas carries a higher risk of exercise-induced hypoglycemia due to 
their longer half-lives. Other recommendations concern safe participation for type 2 
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exercisers with existing or developing diabetes-related complications such as 
cardiovascular disease, hypertension, neuropathy, or microvascular changes. 
2. 7 Managing Diabetic Complications 
People with diabetes may experience a variety of macrovascular and microvascular 
complications that can complicate exercise. Any individual with a high risk for 
underlying cardiovascular disease should undergo a graded exercise test before 
beginning a moderate- to high-intensity exercise program (Swain and Leutholtz, 1997). 
For exercise involving the feet, precautionary measures are recommended, especially if 
peripheral neuropathy is present. Use of silica gel or cushioned midsoles, polyester or 
synthetic-blend socks, and proper footwear is essential to prevent blisters, to keep the 
feet dry, and minimise or prevent trauma. Non-weight-bearing exercise such as aqua 
aerobics can be substituted for weight-bearing activities. Hypotension and hypertension 
following vigorous exercise are more likely to develop in individuals with autonomic 
neuropathy. Their thermoregulatory capacity may be inadequate, and special care is 
needed to maintain adequate hydration. Active, strenuous exercise is contraindicated for 
individuals with active vitreous hemorrhages due to unstable proliferative retinopathy. 
Intense exercise involving straining, jarring, or Valsalva-like maneuvers should be 
avoided as well. When nephropathy is present, individuals may have a reduced exercise 
capacity, but low to moderate-intensity activities can be done. Although the above 
general exercise recommendations can be helpful, physicians may have to aid patients 
in modi tying diet and/or insulin regimens because the recommendations require 
tailoring to meet individual needs. Furthermore, if a patient's pre-exercise metabolic 
control is poor or diabetes-related complications are present, clinical recommendations 
should be followed to prevent worsening or onset of complications. Exercise can be 
24 
